|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
GAAD Medical Research Institute Inc. |
|---|---|
| Information provided by: | GAAD Medical Research Institute Inc. |
| ClinicalTrials.gov Identifier: | NCT00574522 |
Purpose
The investigators are proposing that energy specific electromagnetic radiation of the central nervous system, the viscera and the endocrine system has the potential to enhance the immune system; thereby enhancing the production of killer cells to fight and destroy the human immunodeficiency virus.
| Condition | Intervention | Phase |
|---|---|---|
|
HIV Infections |
Radiation: Far infrared Radiation: Far infrared radiation |
Phase I |
| Study Type: | Interventional |
| Study Design: | Treatment, Open Label, Uncontrolled, Single Group Assignment |
| Official Title: | Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for HIV/AIDS |
| Estimated Enrollment: | 10 |
| Study Start Date: | February 2008 |
| Estimated Study Completion Date: | May 2009 |
| Estimated Primary Completion Date: | March 2009 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| 1 |
Radiation: Far infrared
Far infrared radiation with the wavelength between 5μm and 20μm for 30 to 40 minutes per session.
Radiation: Far infrared radiation
Far infrared radiation with wavelength between 5μm and 20μm. Duration is 30 to 40 minutes per session.
|
Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS or Aids) is a collection of symptoms and infections resulting from the specific damage to the immune system caused by the human immunodeficiency virus (HIV) in humans. The late stage of the condition leaves individuals prone to opportunistic infections and tumors. Although treatments for AIDS and HIV exist to slow the virus' progression, there is no known cure.
We are postulating that energy specific electromagnetic radiation of the central nervous system, the viscera and the endocrine system has the potential to enhance the immune system; thereby enhancing the production of CD4+ T cells and other killer cells to fight and destroy the human immunodeficiency virus.
The primary end point is to determine the therapeutic effects of far infrared radiation (5μm to 20μm wavelength) on HIV/AIDS.
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Kwasi Donyina, Ph.D. | 647-274-9381 | kwasi.donyina@gaadmedresearch.org |
| Contact: Ben Campbell, Ph.D. | 416-314-5871 | ben.campbell@gaadmedresearch.org |
| Canada, Ontario | |
| The Centre for Incurable Diseases | Recruiting |
| Toronto, Ontario, Canada, M4V 1L5 | |
| Contact: Ben Campbell, Ph.D. 416-314-5871 ben.campbell@gaadmedresearch.org | |
| Contact: , Ph.D. | |
| Sub-Investigator: Kwasi Donyina, Ph.D. | |
| Principal Investigator: | Ken Nedd, M.D. | GAAD Medical Research Institute Inc. |
| Study Director: | Kwasi Donyina, Ph.D. | GAAD Medical Research Institute Inc. |
More Information
| Responsible Party: | Centre for Incurable Diseases, GAAD Medical Research Institute Inc. ( Kwasi Donyina, Ph.D./Founder & President ) |
| Study ID Numbers: | GAAD-HIV-CTP1 |
| Study First Received: | December 12, 2007 |
| Last Updated: | January 2, 2009 |
| ClinicalTrials.gov Identifier: | NCT00574522 |
| Health Authority: | Canada: Health Canada |
|
HIV AIDS Radiation Far infrared |
Treatment Acquired Immunodeficiency Syndrome Complimentary therapies |
|
Virus Diseases Sexually Transmitted Diseases, Viral HIV Infections Sexually Transmitted Diseases |
Acquired Immunodeficiency Syndrome Retroviridae Infections Immunologic Deficiency Syndromes |
|
RNA Virus Infections Slow Virus Diseases Immune System Diseases Lentivirus Infections Infection |
